| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |